ICD-10 Code C84.7B | Anaplastic large cell lymphoma, ALK-negative, in remission Symptoms, Diagnosis, Billing

Anaplastic large cell lymphoma (ALCL), ALK-negative, is a type of non-Hodgkin lymphoma characterized by the proliferation of large, anaplastic lymphoid cells. This subtype is associated with a poorer prognosis compared to ALK-positive ALCL. The ICD-10 Code C84.7B is essential for accurate diagnosis, documentation, and billing, facilitating appropriate treatment and public health reporting.

What is ICD-10 Code C84.7B for Anaplastic large cell lymphoma, ALK-negative, in remission?

ICD-10 Code C84.7B specifically denotes Anaplastic large cell lymphoma, ALK-negative, in remission. This code is utilized when documenting patients who have undergone treatment for this aggressive lymphoma subtype and are currently in a state of remission. Accurate coding is crucial for clinical documentation, billing, and tracking treatment outcomes.

ICD-10 Code C84.7B – Clinical Definition and Explanation of Anaplastic large cell lymphoma, ALK-negative, in remission

Anaplastic large cell lymphoma, ALK-negative, is a hematological malignancy that arises from T-cells and is characterized by the presence of large, atypical lymphoid cells. This condition requires prompt medical attention due to its aggressive nature and potential for systemic involvement. The remission status indicates a favorable response to treatment.

Key Clinical Features:

• Presence of large, anaplastic lymphoid cells on histopathological examination.
• Common symptoms include lymphadenopathy, fever, weight loss, and night sweats.
• Higher incidence in young adults and adolescents.
• Potential for extranodal involvement, including skin and soft tissues.

ICD-10 Code C84.7B for Anaplastic large cell lymphoma, ALK-negative, in remission – SOAP Notes & Clinical Use

ICD-10 Code C84.7B is utilized in SOAP notes to document the patient's remission status, treatment response, and ongoing management. This code plays a critical role in both acute and chronic care settings, ensuring comprehensive documentation of the patient's clinical journey.

What Does ICD-10 Code C84.7B for Anaplastic large cell lymphoma, ALK-negative, in remission Mean in SOAP Notes?

In SOAP notes, ICD-10 Code C84.7B connects subjective patient reports and objective clinical findings to a formal diagnosis of Anaplastic large cell lymphoma, ALK-negative, in remission. This ensures continuity of care, supports accurate billing, and meets EHR documentation standards.

Treatment Options for ICD-10 Code C84.7B – Anaplastic large cell lymphoma, ALK-negative, in remission

Management of Anaplastic large cell lymphoma, ALK-negative, in remission focuses on monitoring for relapse and managing any residual symptoms. Treatment may include chemotherapy, targeted therapy, or stem cell transplantation.

Antibiotic Therapy:

• Not applicable as this condition is not infectious.

Supportive Care:

• Regular follow-up appointments to monitor for relapse.
• Symptom management including pain control and nutritional support.
• Psychosocial support for patients and families.

Infection Control:

• Standard precautions to prevent infections in immunocompromised patients.
• Education on hygiene practices and avoiding exposure to infections.

How to Document Symptoms of Anaplastic large cell lymphoma, ALK-negative, in remission (ICD-10 C84.7B) in SOAP Notes

Subjective:

• Patient reports feeling well with no new symptoms.
• Denies fever, night sweats, or weight loss.
• Expresses concern about potential relapse.

Objective:

• Physical examination shows no lymphadenopathy.
• Blood tests indicate normal complete blood count.
• Imaging studies show no evidence of disease.

Secure, compliant, and built for trust

HIPAA-compliant and designed with privacy in mind, your patient’s data is protected. Focus on care while we safeguard your information.

Learn more

SOAP Note Guidelines for Diagnosing Anaplastic large cell lymphoma, ALK-negative, in remission (ICD-10 Code C84.7B)

Assessment:

• Anaplastic large cell lymphoma, ALK-negative, in remission (ICD-10 Code C84.7B).
• No evidence of active disease at this time.
• Patient is stable with no significant symptoms.

Plan:

• Continue regular follow-up every 3 months.
• Monitor for any signs of relapse.
• Provide education on lifestyle modifications and symptom awareness.

Treatment & Plan Section for ICD-10 Code C84.7B – Anaplastic large cell lymphoma, ALK-negative, in remission

• Regular follow-up appointments to monitor for relapse.
• Patient education on signs and symptoms of recurrence.
• Psychosocial support services referral as needed.
• Nutritional counseling to support recovery.

Using ICD-10 Code C84.7B for Anaplastic large cell lymphoma, ALK-negative, in remission in Billing & SOAP Note Compliance

• Ensure accurate documentation of remission status in the Subjective (S) and Objective (O) sections.
• Use C84.7B in conjunction with any relevant treatment codes for comprehensive billing.
• Document any complications or comorbidities that may affect treatment.

Related ICD-10 Codes Often Used with Anaplastic large cell lymphoma, ALK-negative, in remission

• C84.7A – Anaplastic large cell lymphoma, ALK-positive, in remission

ICD-10 Code C84.7B in Medical Billing and Insurance for Anaplastic large cell lymphoma, ALK-negative, in remission

ICD-10 Code C84.7B is critical in medical billing, particularly in hospital and outpatient settings, to ensure accurate reimbursement for services rendered.

Billing Notes:

• Document the patient's remission status clearly in the medical record.
• Use C84.7B in conjunction with treatment codes for comprehensive billing.
• Ensure all relevant clinical findings are included to support the claim.

Common CPT Pairings: